Health and Me on MSN
Duchenne Gene Therapy: Why The FDA Has Tightened Rules Following Two Teen Deaths
The FDA has added a boxed warning to Sarepta’s Duchenne gene therapy Elevidys after two teens died from liver failure and has ...
44 分钟on MSN
Is Regeneron Pharmaceuticals (REGN) One of the Best Gene-Editing Stocks to Buy According to ...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the best gene-editing stocks to buy according to hedge funds. On ...
At the Mayo Clinic, cardiologists Peter Noseworthy, M.D., and John Giudicessi, M.D., Ph.D., are uncovering the earliest signs ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果